Cancer BiologybioRxivPreprint
Cellular stemness identifies high-risk ductal carcinoma in situ and offers a therapeutic interception opportunity
Emily Schueddig, Veena Kochat, Emre Arslan…·Fariba Behbod
This study identifies stemness features in luminal hormone-responsive cells within DCIS that correlate with invasive progression and shows that targeting FOXA1 reduces tumor growth.